ALB and hepatocellular carcinoma: The degree of liver dysfunction and tumor stage are important factors for predicting OS in HCC patients [1]; the ALBI score was recently developed as an objective measure that uses serum concentrations of albumin and bilirubin to assess the degree of hepatic dysfunction and has been validated in patients with different stages of HCC treated with various local and systemic treatment modalities, including surgical resection, RFA, TACE, and sorafenib [18,36].